Abstract

Gastric cancer, also known as stomach cancer, is a significant global health concern and one of the leading causes of cancer-related deaths worldwide. The malignant biological behavior of gastric cancer, characterized by uncontrolled cell growth, invasion, and metastasis, presents considerable challenges for effective treatment and patient survival. However, advancements in research have shed light on the underlying mechanisms driving this aggressive disease. In this article, we explore various strategies aimed at inhibiting the malignant biological behavior of gastric cancer, with the ultimate goal of improving therapeutic outcomes and patient prognosis.